Platelet Function (ADP) Closure Time, in vitro

The Invitro BT with ADP is a platelet function screen that measures how long it takes your blood to form a platelet plug inside a small test cartridge coated with collagen and ADP. It is sometimes called an in vitro bleeding time. The result reflects how well platelets adhere and aggregate under high shear conditions, a process that helps stop everyday bleeding.

This test is one part of platelet function testing. It is often run alongside a companion cartridge that uses epinephrine, because comparing the patterns can help separate medication effects from inherited or acquired platelet problems.

This test helps your clinician investigate easy bruising, nosebleeds, heavy periods, or prolonged bleeding after procedures. It is commonly used to screen for platelet dysfunction and can support evaluation for von Willebrand disease, especially when combined with other laboratory studies.

It may also be influenced by antiplatelet medicines that block platelet activation pathways. Although it is not a definitive monitor for specific drugs, the ADP cartridge is sensitive to changes in the P2Y12 pathway and to more global platelet defects. Results can help guide decisions before surgery or invasive procedures and can prompt targeted follow‑up testing when indicated.

A longer closure time generally suggests reduced platelet function or a related issue, while a normal time suggests that primary hemostasis is likely adequate under the test conditions. Single results are best interpreted alongside your symptoms, medication list, complete blood count, and, if needed, other platelet or von Willebrand tests.

If your result is outside the expected interval, your clinician may review recent drugs, repeat the test after holding nonessential agents, or order follow-up studies such as a von Willebrand panel or formal platelet aggregation testing. Low platelet counts, anemia, kidney disease, and acute illness can prolong the result. If you are scheduled for a procedure, your care team will discuss practical steps to reduce bleeding risk based on the whole clinical picture.